Chronic Ankle Instability Diagnostic Tests Determining Underlying Deficits (CAIDiag)

May 24, 2022 updated by: University Hospital, Lille

Biomechanical Analysis, Complementary Examinations and Rehabilitative Management of Chronic Ankle Instability

Chronic ankle instability is a common condition in the active adult population and characterized by the occurrence of repeated giving way and/or recurrent ankle sprains. Multiple underlying deficits have been proposed, among which ankle muscle strength deficits, proprioception deficits, ( static and dynamic balance disorders, and articular laxity. Unfortunately, no consensus exists on which clinical tests should be realized to determine if one of these underlying deficits is predominant and as a result could guide the rehabilitation process. The study hypothesis is that people with chronic ankle instability might be heterogenous and could be divided in different subgroups as a function of underlying deficits. Therefore, this study aims to evaluate the capacity of different clinical tests to differentiate people with chronic ankle instability from healthy people as well as between each other.

Study Overview

Status

Terminated

Study Type

Observational

Enrollment (Actual)

4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Omer, France
        • CH Saint-Omer, institut audomarois de la chirurgie orthopédique et du sport

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adults (18-45 yrs) living in the northern part of France close to or in Lille, Saint-Omer and Amiens

Description

Inclusion Criteria:

  • Case subject : at least one initial lateral ankle sprain more than 12 months before inclusion
  • Case subject : at least one residual symptom among (1) giving way, (2) sensation of instability, (3) recurrent ankle sprain. This item is confirmed by a score inferior than 24 on the Chronic Ankle Instability Tool (CAIT)
  • Case subject : Impact on activities of daily living and sport, confirmed by a score of less than 90% on the Foot and Ankle Ability Measure (FAAM) and less than 80% on FAAM-- - -- Control subject : matched by age and sex to case subjects

Exclusion Criteria:

  • Surgery of one of the lower limbs less than 3 years ago
  • Presence of heavy pain (EVA > 8) regardless of its origin
  • Acute lateral ankle sprain less than 4 months before inclusion
  • Neurological disorders of any kind
  • Medical treatment (drugs) interfering with muscle tone, balance and proprioception disorders
  • Pregnant or breastfeeding women
  • Body mass index > 30
  • Bilateral chronic ankle instability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Case subjects adult patients with chronic ankle instability

Male or female subjects aged 18-45, presenting :

  • at least one acute lateral ankle sprain (i.e. initial ankle sprain more than 12 months before inclusion),
  • at least one residual symptom (giving way OR sensation of instability OR recurrent ankle sprain), confirmed by a score < 24 on the Chronic Ankle Instability Tool (CAIT)
  • Impact on activities of daily living and sport, score < 90% on Foot and Ankle Ability Measure (FAAM) and < 80% on FAAM-sport Case subjects are free of any other lower extremity pathologies or pain Subjects presenting bilateral chronic ankle instability are excluded
Healthy subjects
Male or female subjects aged 18-45 (matched with case Healthy subjects), without any lower extremity pathologies

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Static balance tests
Time Frame: Baseline

Static balance tests ( DLS and SLS (both ankles tested) ; Stabilometry) are composite measure

  • Centre of Pressure (COP) displacement (mm) ;
  • COP velocity (mm/s)
  • COP area (mm²)
  • COP time-to-boundary (TTB) (s)
  • Number of foot lifts (integer)
Baseline
the Star Excursion Balance Test (SEBT)
Time Frame: Baseline

Dynamic balance test : SEBT (both ankles tested) : are composite measure

  • Distance reached in anterior direction (% leg length)
  • Distance reached in posteromedial direction (% leg length)
  • Distance reached in posterolateral direction (% leg length)
  • Time used to reach (s)
  • COP displacement (mm)
  • COP velocity (s)
  • COP area (mm²)
  • COP time-to-boundary (TTB) (s)
Baseline
Hop tests
Time Frame: Baseline

Hop tests (both ankles tested) : SLHD et SH ; are composite measure

  • Distance reached (m)
  • Max inversion angle ankle joint (°)
  • Max internal rotation angle ankle joint (°)
  • Max vertical Ground Reaction Force (GRF) at landing (N)
  • Max lateral GRF (N)
  • Time used to complete 10 hops (s)
Baseline
Strength tests (both ankles tested)
Time Frame: Baseline

Isokinetic strength tests (both ankles tested) :

  • Plantar flexor peak torque (Nm)
  • Dorsiflexor peak torque (Nm)
  • Inversion peak torque (Nm)
  • Eversion Peak torque (Nm)
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intra-class correlation coefficients (reproducibility test-retest)
Time Frame: Baseline and 1-4 weeks after baseline

Intra-class correlation coefficients (reproducibility test-retest) calculated on the subset of the parameters identified by the main analysis.

Recyclability of the functional clinical tests : Normality testing /Sample comparison

Baseline and 1-4 weeks after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alexandre Arnould, MD, University Hospital, Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 24, 2019

Primary Completion (Actual)

October 25, 2021

Study Completion (Actual)

October 25, 2021

Study Registration Dates

First Submitted

January 9, 2019

First Submitted That Met QC Criteria

January 23, 2019

First Posted (Actual)

January 28, 2019

Study Record Updates

Last Update Posted (Actual)

May 31, 2022

Last Update Submitted That Met QC Criteria

May 24, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2017_09
  • 2018-A00102-53 (Other Identifier: ID-RCB number, ANSM)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe